These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8578446)

  • 1. Thrombin generation in plasma: its assessment via the endogenous thrombin potential.
    Hemker HC; Béguin S
    Thromb Haemost; 1995 Jul; 74(1):134-8. PubMed ID: 8578446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin generation as an intermediate phenotype for venous thrombosis.
    Segers O; van Oerle Rv; ten Cate Ht; Rosing J; Castoldi E
    Thromb Haemost; 2010 Jan; 103(1):114-22. PubMed ID: 20062924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
    Curvers J; Thomassen MC; Rimmer J; Hamulyak K; van der Meer J; Tans G; Preston FE; Rosing J
    Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma.
    Duchemin J; Pan-Petesch B; Arnaud B; Blouch MT; Abgrall JF
    Thromb Haemost; 2008 Apr; 99(4):767-73. PubMed ID: 18392335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardization and clinical utility of thrombin-generation assays.
    Berntorp E; Salvagno GL
    Semin Thromb Hemost; 2008 Oct; 34(7):670-82. PubMed ID: 19085768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography.
    Tchaikovski SN; van Vliet HA; Thomassen MC; Bertina RM; Rosendaal FR; Sandset PM; Helmerhorst FM; Tans G; Rosing J
    Thromb Haemost; 2007 Dec; 98(6):1350-6. PubMed ID: 18064335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The routine determination of the endogenous thrombin potential, first results in different forms of hyper- and hypocoagulability.
    Wielders S; Mukherjee M; Michiels J; Rijkers DT; Cambus JP; Knebel RW; Kakkar V; Hemker HC; Béguin S
    Thromb Haemost; 1997 Apr; 77(4):629-36. PubMed ID: 9134633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin generation, a function test of the haemostatic-thrombotic system.
    Hemker HC; Al Dieri R; De Smedt E; Béguin S
    Thromb Haemost; 2006 Nov; 96(5):553-61. PubMed ID: 17080210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring thrombin generation based sensitivity to activated protein C using an automated coagulometer (ACL 9000).
    Gardiner C; Machin SJ; Mackie IJ
    Int J Lab Hematol; 2008 Aug; 30(4):261-8. PubMed ID: 18665822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependency of thrombin generation measured by means of calibrated automated thrombography (CAT).
    Haidl H; Cimenti C; Leschnik B; Zach D; Muntean W
    Thromb Haemost; 2006 May; 95(5):772-5. PubMed ID: 16676066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of oral contraceptives on the time-integral of thrombin generation (thrombin potential).
    Rotteveel RC; Roozendaal KJ; Eijsman L; Hemker HC
    Thromb Haemost; 1993 Dec; 70(6):959-62. PubMed ID: 8165618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
    Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of maximum thrombin generation capacity in blood and plasma using the thrombin generation assay (THROGA).
    Nowak G; Lange U; Wiesenburg A; Bucha E
    Semin Thromb Hemost; 2007 Jul; 33(5):508-14. PubMed ID: 17629848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
    Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
    J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipid-bound tissue factor modulates both thrombin generation and APC-mediated factor Va inactivation.
    Váradi K; Siekmann J; Turecek PL; Schwarz HP; Marder VJ
    Thromb Haemost; 1999 Dec; 82(6):1673-9. PubMed ID: 10613654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution.
    De Smedt E; Wagenvoord R; Coen Hemker H
    Thromb Haemost; 2009 Jan; 101(1):165-70. PubMed ID: 19132204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls.
    Collins PW; Macchiavello LI; Lewis SJ; Macartney NJ; Saayman AG; Luddington R; Baglin T; Findlay GP
    Br J Haematol; 2006 Oct; 135(2):220-7. PubMed ID: 17010048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V and protein S as cofactors to activated protein C.
    Dahlbäck B
    Haematologica; 1997; 82(1):91-5. PubMed ID: 9107093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring hypocoagulant conditions in rat plasma: factors determining the endogenous thrombin potential of tissue factor-activated plasma.
    Nieuwenhuys CM; Feijge MA; Béguin S; Heemskerk JW
    Thromb Haemost; 2000 Dec; 84(6):1045-51. PubMed ID: 11154112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A guide for diagnosis of patients with arterial and venous thrombosis.
    Quinn C; Hill J; Hassouna H
    Clin Lab Sci; 2000; 13(4):229-38. PubMed ID: 11586510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.